Biologically active sphingolipids in cancer pathogenesis and treatment
- 1 August 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 4 (8), 604-616
- https://doi.org/10.1038/nrc1411
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Beyond Parkinson Disease: Amyotrophic Lateral Sclerosis and the Axon Guidance PathwayPLOS ONE, 2008
- Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham studyBMC Medical Genetics, 2007
- Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathwayThe Journal of cell biology, 2004
- Sphingosine Kinase Type 1 Induces G12/13-mediated Stress Fiber Formation, yet Promotes Growth and Survival Independent of G Protein-coupled ReceptorsOnline Journal of Public Health Informatics, 2003
- Nitric Oxide Induces Degradation of the Neutral Ceramidase in Rat Renal Mesangial Cells and Is Counterregulated by Protein Kinase COnline Journal of Public Health Informatics, 2002
- Ceramide levels are inversely associated with malignant progression of human glial tumorsGlia, 2002
- FTY720, a Novel Immunosuppressive Agent, Induces Apoptosis in Human Glioma CellsBiochemical and Biophysical Research Communications, 2001
- Regulation of Cyclin-Dependent Kinase 2 Activity by CeramideExperimental Cell Research, 2000
- Overexpression of Acid Ceramidase Protects from Tumor Necrosis Factor–Induced Cell DeathThe Journal of Experimental Medicine, 2000
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995